Question 1

What are the potential benefits of adding the DC1 vaccine to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab clinical trial (NCT05325632). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab clinical trial (NCT05325632). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of the vaccine and the standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab clinical trial (NCT05325632). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and tests during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab clinical trial (NCT05325632). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab clinical trial (NCT05325632). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my participation in this trial affect my eligibility for other treatments in the future?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab clinical trial (NCT05325632). Contact the study team or your healthcare provider for specific answers.

What this study is about